New Haven's Biohaven eyes new version of migraine drug
The biotech company's migraine drug is approved by the FDA, but a new nasal version acts more quickly and with fewer side effects, officials said. |!| New Haven
More from Greater New Haven
Southern Connecticut State Owls
SCSU Field Hockey Tops St. Michael's, 5-2, For Kelley Frassinelli's 200th Career Win
Greater New Haven
•
1h ago
New Haven Register
State park in Hamden closes Sunday morning after reaching its parking capacity, DEEP says
Greater New Haven
•
4h ago
New Haven Register
UConn women's basketball team vs. Texas, exhibition: Time, TV, tickets, lineups and more
Greater New Haven
•
4h ago
New Haven Register
Connecticut early voting starts Monday. Here's where you can cast a ballot.
Greater New Haven
•
10h ago
New Haven Register
AI is entering Connecticut's utility systems. Officials want to know the risks
Greater New Haven
•
11h ago
New Haven Register
West Haven council urges library to maximize $1 million in ARPA funding
Greater New Haven
•
11h ago
New Haven Register
From dissecting whales to shaping 'Whalefall': Meet the former CT scientist behind the story's realism
Greater New Haven
•
11h ago